Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months

• Published in: Pediatric diabetes Vol. 21; no. 2; pp. 319 - 327
• Main Authors: Messer, Laurel H., Berget, Cari, Vigers, Tim, Pyle, Laura, Geno, Cristy, Wadwa, R. Paul, Driscoll, Kimberly A., Forlenza, Gregory P.
• Format: Journal Article
• Language: English
• Published: Former Munksgaard John Wiley & Sons A/S 01.03.2020; John Wiley & Sons, Inc
• Subjects: Adolescent; Adult; artificial pancreas; Child; continuous glucose monitor; Diabetes; Diabetes mellitus (insulin dependent); Diabetes Mellitus, Type 1 - drug therapy; Diabetes Mellitus, Type 1 - psychology; Female; Glucose monitoring; Humans; hybrid closed loop; Hypoglycemia; Insulin Infusion Systems - psychology; insulin pump; Male; Patient Dropouts - psychology; pediatrics; type 1 diabetes; Young Adult; hybrid closed loop; type 1 diabetes; continuous glucose monitor; artificial pancreas; insulin pump; pediatrics
• ISSN: 1399-543X; 1399-5448; 1399-5448
• DOI: 10.1111/pedi.12971

Objective To describe predictors of hybrid closed loop (HCL) discontinuation and perceived barriers to use in youth with type 1 diabetes. Subjects Youth with type 1 diabetes (eligible age 2‐25 y; recruited age 8‐25 y) who initiated the Minimed 670G HCL system were followed prospectively for 6 mo in an observational study. Research Design and Methods Demographic, glycemic (time‐in‐range, HbA1c), and psychosocial variables [Hypoglycemia Fear Survey (HFS); Problem Areas in Diabetes (PAID)] were collected for all participants. Participants who discontinued HCL (<10% HCL use at clinical visit) completed a questionnaire on perceived barriers to HCL use. Results Ninety‐two youth (15.7 ± 3.6 y, HbA1c 8.8 ± 1.3%, 50% female) initiated HCL, and 28 (30%) discontinued HCL, with the majority (64%) discontinuing between 3 and 6 mo after HCL start. Baseline HbA1c predicted discontinuation (P = .026) with the odds of discontinuing 2.7 times higher (95% CI: 1.123, 6.283) for each 1% increase in baseline HbA1c. Youth who discontinued HCL rated difficulty with calibrations, number of alarms, and too much time needed to make the system work as the most problematic aspects of HCL. Qualitatively derived themes included technological difficulties (error alerts, not working correctly), too much work (calibrations, fingersticks), alarms, disappointment in glycemic control, and expense (cited by parents). Conclusions Youth with higher HbA1c are at greater risk for discontinuing HCL than youth with lower HbA1c, and should be the target of new interventions to support device use. The primary reasons for discontinuing HCL relate to the workload required to use HCL.